213 related articles for article (PubMed ID: 25523517)
1. Infantile hemangiomas, retinopathy of prematurity and cancer: a common pathogenetic role of the β-adrenergic system.
Filippi L; Dal Monte M; Casini G; Daniotti M; Sereni F; Bagnoli P
Med Res Rev; 2015 May; 35(3):619-52. PubMed ID: 25523517
[TBL] [Abstract][Full Text] [Related]
2. Role of the adrenergic system in a mouse model of oxygen-induced retinopathy: antiangiogenic effects of beta-adrenoreceptor blockade.
Ristori C; Filippi L; Dal Monte M; Martini D; Cammalleri M; Fortunato P; la Marca G; Fiorini P; Bagnoli P
Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):155-70. PubMed ID: 20739470
[TBL] [Abstract][Full Text] [Related]
3. The β-adrenergic system as a possible new target for pharmacologic treatment of neovascular retinal diseases.
Casini G; Dal Monte M; Fornaciari I; Filippi L; Bagnoli P
Prog Retin Eye Res; 2014 Sep; 42():103-29. PubMed ID: 24933041
[TBL] [Abstract][Full Text] [Related]
4. Antiangiogenic effects of β2 -adrenergic receptor blockade in a mouse model of oxygen-induced retinopathy.
Martini D; Monte MD; Ristori C; Cupisti E; Mei S; Fiorini P; Filippi L; Bagnoli P
J Neurochem; 2011 Dec; 119(6):1317-29. PubMed ID: 21988318
[TBL] [Abstract][Full Text] [Related]
5. Propranolol inhibition of β-adrenergic receptor does not suppress pathologic neovascularization in oxygen-induced retinopathy.
Chen J; Joyal JS; Hatton CJ; Juan AM; Pei DT; Hurst CG; Xu D; Stahl A; Hellstrom A; Smith LE
Invest Ophthalmol Vis Sci; 2012 May; 53(6):2968-77. PubMed ID: 22491401
[TBL] [Abstract][Full Text] [Related]
6. The pathophysiology of retinopathy of prematurity: an update of previous and recent knowledge.
Cavallaro G; Filippi L; Bagnoli P; La Marca G; Cristofori G; Raffaeli G; Padrini L; Araimo G; Fumagalli M; Groppo M; Dal Monte M; Osnaghi S; Fiorini P; Mosca F
Acta Ophthalmol; 2014 Feb; 92(1):2-20. PubMed ID: 23617889
[TBL] [Abstract][Full Text] [Related]
7. Beta-adrenoreceptor agonism influences retinal responses to hypoxia in a model of retinopathy of prematurity.
Dal Monte M; Martini D; Latina V; Pavan B; Filippi L; Bagnoli P
Invest Ophthalmol Vis Sci; 2012 Apr; 53(4):2181-92. PubMed ID: 22410551
[TBL] [Abstract][Full Text] [Related]
8. β3-Adrenoceptor, a novel player in the round-trip from neonatal diseases to cancer: Suggestive clues from embryo.
Filippi L; Pini A; Cammalleri M; Bagnoli P; Dal Monte M
Med Res Rev; 2022 May; 42(3):1179-1201. PubMed ID: 34967048
[TBL] [Abstract][Full Text] [Related]
9. Study protocol: safety and efficacy of propranolol in newborns with Retinopathy of Prematurity (PROP-ROP): ISRCTN18523491.
Filippi L; Cavallaro G; Fiorini P; Daniotti M; Benedetti V; Cristofori G; Araimo G; Ramenghi L; La Torre A; Fortunato P; Pollazzi L; la Marca G; Malvagia S; Bagnoli P; Ristori C; Dal Monte M; Bilia AR; Isacchi B; Furlanetto S; Tinelli F; Cioni G; Donzelli G; Osnaghi S; Mosca F
BMC Pediatr; 2010 Nov; 10():83. PubMed ID: 21087499
[TBL] [Abstract][Full Text] [Related]
10. Eye drop propranolol administration promotes the recovery of oxygen-induced retinopathy in mice.
Dal Monte M; Casini G; la Marca G; Isacchi B; Filippi L; Bagnoli P
Exp Eye Res; 2013 Jun; 111():27-35. PubMed ID: 23528535
[TBL] [Abstract][Full Text] [Related]
11. Infantile hemangiomas β
Bassi A; Filippeschi C; Oranges T; Caporalini C; Pini A; Nardini P; Gentile RM; Filippi L
Pediatr Res; 2022 Jan; 91(1):163-170. PubMed ID: 33654276
[TBL] [Abstract][Full Text] [Related]
12. Study protocol: safety and efficacy of propranolol 0.2% eye drops in newborns with a precocious stage of retinopathy of prematurity (DROP-ROP-0.2%): a multicenter, open-label, single arm, phase II trial.
Filippi L; Cavallaro G; Berti E; Padrini L; Araimo G; Regiroli G; Bozzetti V; De Angelis C; Tagliabue P; Tomasini B; Buonocore G; Agosti M; Bossi A; Chirico G; Aversa S; Pasqualetti R; Fortunato P; Osnaghi S; Cavallotti B; Vanni M; Borsari G; Donati S; Nascimbeni G; la Marca G; Forni G; Milani S; Cortinovis I; Bagnoli P; Dal Monte M; Calvani AM; Pugi A; Villamor E; Donzelli G; Mosca F
BMC Pediatr; 2017 Jul; 17(1):165. PubMed ID: 28709412
[TBL] [Abstract][Full Text] [Related]
13. Oral propranolol for retinopathy of prematurity: risks, safety concerns, and perspectives.
Filippi L; Cavallaro G; Bagnoli P; Dal Monte M; Fiorini P; Donzelli G; Tinelli F; Araimo G; Cristofori G; la Marca G; Della Bona ML; La Torre A; Fortunato P; Furlanetto S; Osnaghi S; Mosca F
J Pediatr; 2013 Dec; 163(6):1570-1577.e6. PubMed ID: 24054431
[TBL] [Abstract][Full Text] [Related]
14. β-Adrenergic receptor antagonists inhibit vasculogenesis of embryonic stem cells by downregulation of nitric oxide generation and interference with VEGF signalling.
Sharifpanah F; Saliu F; Bekhite MM; Wartenberg M; Sauer H
Cell Tissue Res; 2014 Nov; 358(2):443-52. PubMed ID: 25130141
[TBL] [Abstract][Full Text] [Related]
15. Propranolol represses infantile hemangioma cell growth through the β2-adrenergic receptor in a HIF-1α-dependent manner.
Li P; Guo Z; Gao Y; Pan W
Oncol Rep; 2015 Jun; 33(6):3099-107. PubMed ID: 25872592
[TBL] [Abstract][Full Text] [Related]
16. The Efficacy of Propranolol in Retinopathy of Prematurity and its Correlation with the Platelet Mass Index.
Korkmaz L; Baştuğ O; Ozdemir A; Korkut S; Karaca C; Akin MA; Gunes T; Kurtoglu S; Ozturk MA
Curr Eye Res; 2017 Jan; 42(1):88-97. PubMed ID: 27260268
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of β1/2 adrenergic receptor deletion in a model of oxygen-induced retinopathy.
Dal Monte M; Cammalleri M; Mattei E; Filippi L; Bagnoli P
Invest Ophthalmol Vis Sci; 2014 Dec; 56(1):59-73. PubMed ID: 25503457
[TBL] [Abstract][Full Text] [Related]
18. Functional involvement of β3-adrenergic receptors in melanoma growth and vascularization.
Dal Monte M; Casini G; Filippi L; Nicchia GP; Svelto M; Bagnoli P
J Mol Med (Berl); 2013 Dec; 91(12):1407-19. PubMed ID: 23907236
[TBL] [Abstract][Full Text] [Related]
19. Expression of β-Adrenergic Receptor Subtypes in Proliferative, Involuted, and Propranolol-Responsive Infantile Hemangiomas.
Phillips JD; Zhang H; Wei T; Richter GT
JAMA Facial Plast Surg; 2017 Mar; 19(2):102-107. PubMed ID: 27737446
[TBL] [Abstract][Full Text] [Related]
20. Propranolol: a new pharmacologic approach to counter retinopathy of prematurity progression.
Pascarella F; Scaramuzzo RT; Pini A; Cammalleri M; Bagnoli P; Ciantelli M; Filippi L
Front Pediatr; 2024; 12():1322783. PubMed ID: 38292211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
